LON:SYNC Syncona (SYNC) Share Price, News & Analysis → Nvidia is now part of $3 Trillion Market Cap Club (From Weiss Ratings) (Ad) Free SYNC Stock Alerts GBX 108.40 +1.00 (+0.93%) (As of 06/12/2024 ET) Add Compare Share Share Today's Range 107.40▼ 110.2050-Day Range 107.40▼ 128.4052-Week Range 105▼ 160.80Volume512,410 shsAverage Volume836,949 shsMarket Capitalization£711.00 millionP/E RatioN/ADividend Yield1.85%Price TargetGBX 230 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Get Syncona alerts: Email Address Syncona MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside112.2% UpsideGBX 230 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.13 out of 5 stars 3.5 Analyst's Opinion Consensus RatingSyncona has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSyncona has received no research coverage in the past 90 days.Read more about Syncona's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SYNC. Previous Next 0.8 Dividend Strength Dividend YieldSyncona pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSyncona does not have a long track record of dividend growth.Read more about Syncona's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SYNC. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 2 people have searched for SYNC on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Syncona insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.18% of the stock of Syncona is held by insiders.Percentage Held by Institutions64.85% of the stock of Syncona is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Syncona's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Syncona is -433.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Syncona is -433.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSyncona has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsBig Tech is spending billions each month on Nvidia’s AI superprojectA small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown right now, but that won’t be the case much longer.Click here to find out who they are today. About Syncona Stock (LON:SYNC)Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.Read More SYNC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SYNC Stock News HeadlinesMay 3, 2024 | lse.co.ukLONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTecApril 11, 2024 | lse.co.ukSyncona agrees to sell stake in investee company for GBP7.4 millionApril 9, 2024 | markets.businessinsider.com4BIO Capital Portfolio Company Ascend Acquires Florida-Based GMP Manufacturing CapacityApril 8, 2024 | markets.businessinsider.comOMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah TeichmannMarch 14, 2024 | lse.co.ukSyncona portfolio company Autolus posts widened loss for 2023February 21, 2024 | finanznachrichten.deFreeline Therapeutics Holdings plc: Acquisition of Freeline by Syncona Becomes EffectiveFebruary 10, 2024 | thetimes.co.ukShortlist revealed for NED awardsFebruary 8, 2024 | finanznachrichten.deBioNTech SE: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage ProgramsFebruary 8, 2024 | lse.co.ukSyncona portfolio strengthens in third quarter thanks to AutolusFebruary 8, 2024 | lse.co.ukUPDATE: Syncona portfolio strengthens thanks to AutolusJanuary 19, 2024 | lse.co.ukSyncona says Freeline trial for Gaucher disease treatment positiveDecember 14, 2023 | bbc.comSynconaDecember 4, 2023 | markets.businessinsider.comSyncona Portfolio Firm Beacon's AGTC-501 Trial Shows Positive Data In X-Linked Retinitis PigmentosaNovember 23, 2023 | msn.comBRIEF-Syncona Ltd To Acquire Freeline TherapeuticsNovember 22, 2023 | marketwatch.comFreeline Therapeutics Shares Rise on Takeover by SynconaNovember 22, 2023 | msn.comGene Therapy Player Freeline Therapeutics Goes Private In $28M DealNovember 22, 2023 | marketwatch.comFreeline Therapeutics Agrees to Buyout by SynconaNovember 22, 2023 | markets.businessinsider.comFreeline Therapeutics To Be Bought By Syncona For $28.3 Mln In Cash; Freeline Stock UpNovember 22, 2023 | msn.comFreeline Therapeutics to be acquired by Syncona for $28.3M in cashNovember 22, 2023 | finance.yahoo.comSyncona to Acquire Freeline TherapeuticsNovember 16, 2023 | lse.co.ukSyncona reports declining asset value as investment head steps downOctober 18, 2023 | markets.businessinsider.comSyncona Proposes To Acquire Freeline TherapeuticsOctober 18, 2023 | msn.comFreeline gains on non-binding buyout offer from SynconaOctober 18, 2023 | marketwatch.comSyncona Seeks to Buy Remaining Shares of Freeline TherapeuticsOctober 16, 2023 | finance.yahoo.comSwanBio Evolves Leadership Team with Appointment of Executive Chair and Chief Operating OfficerSee More Headlines Receive SYNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:SYNC Previous SymbolLON:BACT CUSIPN/A CIKN/A Webwww.bacitltd.com Phone17168531362FaxN/AEmployees1,208Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 230 High Stock Price TargetGBX 230 Low Stock Price TargetGBX 230 Potential Upside/Downside+111.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-165,380,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-12.88% Return on Assets-7.77% Debt Debt-to-Equity Ratio64.05 Current Ratio1.24 Quick Ratio0.53 Sales & Book Value Annual Sales£-144,460,000.00 Price / Sales-4.94 Cash FlowGBX 92.64 per share Price / Cash Flow1.17 Book ValueGBX 179 per share Price / Book0.61Miscellaneous Outstanding Shares655,900,000Free FloatN/AMarket Cap£713.62 million OptionableNot Optionable Beta0.26 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Thomas Henderson (Age 57)Co-Founder & Non-Exec. Director Dr. Martin Patrick Murphy Ph.D. (Age 55)Chief Exec. Officer Mr. John McDonald (Age 58)Co-Founder Mr. Rolf Kristian Berndtson Soderstrom ACA (Age 57)BA, Chief Financial Officer Mr. Ben WoolvenBus. Strategy and Operations PartnerDr. Christopher J. Hollowood Ph.D. (Age 48)CIO & Managing Partner of Syncona Investment Management Ltd. Ms. Annabel ClarkHead of Investor Relations and CommunicationsMr. Andrew CossarGen. CounselMs. Fenella DernieExec. OfficerMr. Edward Eliot Hodgkin DPhil (Age 60)Managing Partner More ExecutivesKey CompetitorsabrdnLON:ABDNJPMorgan Global Growth & IncomeLON:JGGIRIT Capital PartnersLON:RCPMonksLON:MNKSHICL InfrastructureLON:HICLView All Competitors SYNC Stock Analysis - Frequently Asked Questions Should I buy or sell Syncona stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syncona in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SYNC shares. View SYNC analyst ratings or view top-rated stocks. What is Syncona's stock price target for 2024? 1 Wall Street research analysts have issued twelve-month price objectives for Syncona's stock. Their SYNC share price targets range from GBX 230 to GBX 230. On average, they anticipate the company's share price to reach GBX 230 in the next year. This suggests a possible upside of 112.2% from the stock's current price. View analysts price targets for SYNC or view top-rated stocks among Wall Street analysts. How have SYNC shares performed in 2024? Syncona's stock was trading at GBX 123.40 on January 1st, 2024. Since then, SYNC stock has decreased by 12.2% and is now trading at GBX 108.40. View the best growth stocks for 2024 here. Is Syncona a good dividend stock? Syncona (LON:SYNC) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.04%. Read our dividend analysis for SYNC. What other stocks do shareholders of Syncona own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include Rexahn Pharmaceuticals (REXN), Barrick Gold (ABX), Agnico Eagle Mines (AEM), Franco-Nevada (FNV), Goldex Resources (GDX), VanEck Gold Miners ETF (GDX), Goldcorp (GG), Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK). How do I buy shares of Syncona? Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SYNC) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredPotentially Pocket $767/Day with AIWhat if I told you it could take just $9… To win 90% of your options trades?Trade Machine | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Share Syncona With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.